|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.75 CNY | -2.25% |
|
-5.17% | -19.52% |
Shandong Sinobioway Biomedicine Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 429.79 million compared to CNY 357.08 million a year ago. Net loss was CNY 332.46 million compared to CNY 14.68 million a year ago.
Basic loss per share from continuing operations was CNY 0.5039 compared to CNY 0.0223 a year ago. Diluted loss per share from continuing operations was CNY 0.5039 compared to CNY 0.0223 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -19.52% | 1.07B | |
| -1.98% | 90.27B | |
| +1.32% | 40.12B | |
| -15.73% | 31.75B | |
| +64.13% | 26.6B | |
| -21.28% | 14.41B | |
| -8.50% | 12.92B | |
| -44.07% | 11.3B | |
| -13.06% | 11.44B | |
| +4.94% | 8.87B |
SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD. 
